Morgans have tipped a lot of their clients into this stock at significant multiples of 2.5 cents. They would have to be disappointed with the delays with cpn10. What I have found frustrating is the lack of information on the 100mg dosage. This time last year they were predicting completion and a partnering deal at the end of 2014. Dr Collier has said on a number of occasions this year that they would report June 2015 ( 1 day to go ). Recruitment is still open on this trial presumably for a 300mg cohort? Have we been given approval yet to go to this dose?
Maybe Morgans can enlighten us?
IVX Price at posting:
1.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)